EVOLVA

Welcome to the Brand page for “EVOLVA”, which is offered here for Pharmaceutical, medical and veterinary preparations, drugs, nutraceuticals, gene therapy products, medical and pharmaceutical screening products, enzymes and enzyme preparations for medical and veterinary purposes, medical diagnostic preparations and reagents composed of polynucleic acids and polypeptides; herbicides, pesticides, biopesticides, miticides and weed-killers, all for agricultural and domestic use; vaccines, adjuvants for use with vaccines; intermediate semi-synthetic drugs, hormones;polynucleic acids and polypeptides for scientific, research and commercial use; chemicals for scientific use, research and commercial use, the aforementioned to be used in vitro and in vivo; plant growth regulators, polypeptides, genes, and other genetic material for agricultural use; genes and enzymes used to produce chemicals for research and commercial applications pertaining to chemistry, biochemistry, biology, agriculture, pharmaceuticals, diagnostics, medicine, cosmetics, bioremediation, decontamination, detoxification and cleaning, transgenic micro organisms, libraries of micro organisms, nanostructures;scientific and industrial research, in particular drug discovery, cell discovery, gene research, enzyme research, molecular research, genomics and gene expression research and development, medical and pharmaceutical screening, development and creation of gene libraries, generation of molecules; development of combination of genes to produce novel gene pathways for use in science, research, chemistry, agriculture, medicine and industry; research and product development services in the field of genetics, pharmaceuticals, bacteriology, virology, metabolic pathways and biochemical pathways;.

Its status is currently believed to be active. Its class is unavailable. “EVOLVA” is believed to be currently owned by “Evolva Ltd., c/o Dr. iur. Martin Eisenring”.